Exacerbation of psychosis triggered by a synthetic cannabinoid in a 70-year-old woman with Parkinson disease

CMAJ. 2018 Jan 15;190(2):E50-E52. doi: 10.1503/cmaj.170361.

¹ Division of Neurology, Department of Medicine (Udow, Freitas, Fox, Lang), University of Toronto, Toronto, Ont.; Morton and Gloria Shulman Movement Disorders Clinic, and the Edmond J. Safra Program in Parkinson's Disease (Udow, Freitas, Fox, Lang), Toronto Western Hospital, University Health Network, Toronto, Ont.; Section of Neurology, Department of Internal Medicine (Udow), University of Manitoba, Winnipeg, Man.; Deer Lodge Movement Disorders Centre (Udow), Winnipeg, Man. [email protected].
² Division of Neurology, Department of Medicine (Udow, Freitas, Fox, Lang), University of Toronto, Toronto, Ont.; Morton and Gloria Shulman Movement Disorders Clinic, and the Edmond J. Safra Program in Parkinson's Disease (Udow, Freitas, Fox, Lang), Toronto Western Hospital, University Health Network, Toronto, Ont.; Section of Neurology, Department of Internal Medicine (Udow), University of Manitoba, Winnipeg, Man.; Deer Lodge Movement Disorders Centre (Udow), Winnipeg, Man.

No abstract available

Publication types